37 filings
Page 2 of 2
8-K
3tfce
21 Jul 22
Amendments to Articles of Incorporation or Bylaws
4:34pm
8-K
mucdlixg7nvo5
1 Jun 22
Entry into a Material Definitive Agreement
5:02pm
8-K
7tcho7bowln336kiyo3j
19 May 22
Indaptus Therapeutics Announces FDA Clearance of Investigational New Drug
7:51am
8-K
2xxi3pm9
12 May 22
Indaptus Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
8:16am
8-K
hgdd5hbgg
21 Mar 22
Indaptus Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update
7:11am
8-K
3nf6d kmqq0da
1 Feb 22
Departure of Directors or Certain Officers
4:58pm
8-K
t66l0xxo
3 Jan 22
Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer
7:38am
8-K
wikeucvnykefhofxua
2 Dec 21
Departure of Directors or Certain Officers
8:00am
8-K
f2639a2
15 Nov 21
Indaptus Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
7:17am
8-K
j6wucbw7i93
16 Aug 21
Unaudited Financial Statements
4:10pm
8-K/A
winb51gucy7rmjdn48
16 Aug 21
Cost Associated with Exit or Disposal Activities
4:05pm
8-K
4yj933nm51ix 5xk
6 Aug 21
Intec Closes Merger with Decoy Biosystems
5:29pm
8-K
4t01lfoux9euiu6
6 Aug 21
Intec Closes Merger with Decoy Biosystems
5:29pm
8-K
o49x30vk6e2r9qp5b9u
29 Jul 21
Entry into a Material Definitive Agreement
5:16pm
8-K
2neh929qztcx0ns3igb
23 Jul 21
Departure of Directors or Certain Officers
4:30pm
8-K
mlp4sc f1k
16 Jul 21
Other Events
5:11pm
8-K
ywbbszry
22 Jun 21
Other Events
9:07am